Delivery Order SPE2DB20D9127-SPE2DB21FY28U

Award Date 3/10/21
Potential Completion Date 3/31/21
Potential Value $37K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers the provision of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) as a delivery order under the SPE2DB indefinite delivery contract valued up to $499,999,999. The contract is for the delivery of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract covers a wide range of pharmaceutical products, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a delivery order against an existing Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers the provision of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $1,181.86 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The contract provides for the delivery of a variety of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract valued at up to $499,999,999. The contract, with a ceiling value of $18,526.83 and a completion date of October 3, 2024, is for the delivery of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $18,526.83 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The contract, which runs through December 31, 2025, is for the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under a larger indefinite delivery contract (SPE2DB) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The order, worth $37,422.87, is for a wide range of pharmaceutical products and medical supplies to support the recurring needs of military health facilities worldwide. DMS Pharmaceutical Group specializes in providing branded and generic prescription drugs,...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB21FY28U
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers the provision of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The current delivery order has a ceiling value of $37,224.96 and is a firm fixed-price contract with no set-aside designation. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its expertise and capabilities to deliver a diverse array of specialized medications and medical supplies to the Department of Defense.

Generated 2/27/25, 12:42 PM